# Correction: Ahmad et al. Formulation and Optimization of Repaglinide Nanoparticles Using Microfluidics for Enhanced Bioavailability and Management of Diabetes. Biomedicines 2023, 11, 1064

**Authors:** Mubashir Ahmad, Shahzeb Khan, Syed Muhammad Hassan Shah, Muhammad Zahoor, Zahid Hussain, Haya Hussain, Syed Wadood Ali Shah, Riaz Ullah, Amal Alotaibi

PMC · DOI: 10.3390/biomedicines13112795 · 2025-11-17

## Full-text entities

- **Diseases:** Diabetes (MESH:D003920)
- **Chemicals:** Repaglinide (MESH:C072379)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12650288/full.md

---
Source: https://tomesphere.com/paper/PMC12650288